ICU Medical, Inc. (ICUI)
NASDAQ: ICUI · Real-Time Price · USD
164.95
-1.07 (-0.64%)
Sep 25, 2026, 4:00 PM EDT - Market closed
ICU Medical Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4,125 | 3,522 | 3,799 | 2,408 | 3,777 | 5,041 | |
Market Cap Growth | 32.06% | -7.30% | 57.79% | -36.25% | -25.08% | 12.01% |
Enterprise Value | 5,109 | 4,601 | 5,134 | 3,892 | 5,241 | 4,549 |
Last Close Price | 164.95 | 142.67 | 155.17 | 99.74 | 157.48 | 237.34 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 137.04 | 4811.54 | - | - | - | 48.88 |
Forward PE | 53.56 | 178.72 | 33.92 | 33.92 | 33.92 | 47.09 |
PS Ratio | 1.91 | 1.58 | 1.60 | 1.07 | 1.66 | 3.83 |
PB Ratio | 1.92 | 1.66 | 1.93 | 1.13 | 1.81 | 3.12 |
P/TBV Ratio | 41.33 | - | - | - | - | 3.64 |
P/FCF Ratio | 26.99 | 38.37 | 30.48 | 29.25 | - | 25.33 |
P/OCF Ratio | 17.45 | 19.58 | 18.62 | 14.49 | - | 18.84 |
PEG Ratio | 4.87 | 16.25 | 31.81 | 31.81 | 3.08 | 4.28 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.37 | 2.06 | 2.15 | 1.72 | 2.30 | 3.46 |
EV/EBITDA Ratio | 15.67 | 14.84 | 16.20 | 14.07 | 22.63 | 19.68 |
EV/EBIT Ratio | 40.92 | 42.08 | 52.71 | 81.36 | - | 32.17 |
EV/FCF Ratio | 33.43 | 50.12 | 41.19 | 47.29 | - | 22.86 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.60 | 0.64 | 0.84 | 0.80 | 0.83 | 0.03 |
Debt / EBITDA Ratio | 3.76 | 4.12 | 4.85 | 5.67 | 6.84 | 0.19 |
Debt / FCF Ratio | 8.42 | 14.74 | 13.18 | 20.71 | - | 0.24 |
Net Debt / Equity Ratio | 0.46 | 0.49 | 0.67 | 0.67 | 0.71 | -0.32 |
Net Debt / EBITDA Ratio | 3.02 | 3.36 | 4.18 | 5.15 | 6.44 | -2.26 |
Net Debt / FCF Ratio | 6.44 | 11.34 | 10.61 | 17.32 | -9.79 | -2.62 |
Asset Turnover | 0.54 | 0.54 | 0.56 | 0.51 | 0.71 | 0.72 |
Inventory Turnover | 2.18 | 2.35 | 2.41 | 2.16 | 3.21 | 2.73 |
Quick Ratio | 1.00 | 0.99 | 0.90 | 0.92 | 0.95 | 3.38 |
Current Ratio | 2.43 | 2.39 | 2.59 | 2.54 | 2.50 | 5.13 |
Return on Equity (ROE) | 1.41% | 0.04% | -5.76% | -1.41% | -4.01% | 6.62% |
Return on Assets (ROA) | 1.93% | 1.66% | 1.42% | 0.67% | -0.07% | 4.85% |
Return on Invested Capital (ROIC) | 3.96% | 0.78% | 2.85% | 1.34% | -0.15% | 10.58% |
Return on Capital Employed (ROCE) | 3.60% | 3.10% | 2.70% | 1.20% | -0.10% | 8.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.73% | 0.02% | -3.10% | -1.23% | -1.97% | 2.05% |
FCF Yield | 3.71% | 2.61% | 3.28% | 3.42% | -4.04% | 3.95% |
Buyback Yield / Dilution | -2.28% | -2.12% | -1.23% | -0.93% | -9.58% | -0.88% |